Vinorelbine (VNR), ifosfamide (IFO) and cisplatin (CDDP) as assitencial treatment in patients (PTS) with inoperable non small cell lung cancer (NSCLC)Publication » Vinorelbine (VNR), ifosfamide (IFO) and cisplatin (CDDP) as assitencial treatment in patients (PTS) with inoperable non small ...
VNR was administered on day 1 and 8, and CDDP and MMC on day 1. The second course was started after 4 weeks and the further courses were repeated every 6 weeks. In phase I, leukopenia was considered to be dose-limiting toxicity. In level 4 (VNR 25 mg/m2, CDDP 80 mg/m2, MMC 8...
Vinorelbine (VNR), ifosfamide (IFO) and cisplatin (CDDP) as assitencial treatment in patients (PTS) with inoperable non small cell lung cancer (NSCLC)doi:10.1016/s0169-5002(00)80180-4Montalar, JMorales, SVadell, CMaestu, ITorregrosa, M.D...
205 Phase I鈥揑I study of vinorelbine (VNR), cisplatin (CDDP) and mitomycin C (MMC) in non-small cell lung cancer (NSCLC)OgawaraFuruseNishiwakiTakadaFukuoka
Natale, M.De Cataldis, G.Manzione, L.Bilancia, D.Cioffi, R.European Journal of CancerComella P, Panza N, Frasci G et al (1997) Gemcitabine (GEM)-cisplatin (CDDP)- vinorelbine (VNR) combination in advanced non-small cell lung cancer (NSCLC). A phase II randomized study. Lung Cancer ...
A phase II study of induction CDDP+VNR+MMC followed by concomitant-boost thoracic radiotherapy with concurrent daily CDDP for unresectable locally advanced NSCLC (LA-NSCLC): P2-209Methadone maintenancecocaine usedaily activitypatterns of drug use...
Phase II study of cisplatin (CDDP), ifosfamide (IFX) and vinorelbine (VNR) in stage-IIIB-IV NSCLCdoi:10.1016/0959-8049(94)90813-3E. BaldiniC. TibaldiA. ChellaC.A. AngelettiG. SilvanoP.F. ConteEuropean Journal of Cancer
P-212 Split-dose cisplatin (CDDP) and vinorelbine (VNR) in advanced non-small cell lung cancer (NSCLC): treatment outcomes including health-related quality of life (HRQL)doi:10.1016/S0169-5002(03)92181-7Lee, Christopher W.Murray, Nevin...
Gemcitabine (GEM)-cisplatin (CDDP)-vinorelbine (VNR) combination in advanced non-small cell lung cancer (NSCLC): a phase II randomized study [abstract no. *1615]. Thirty-Third Annual Meeting, American Society of Clinical Oncologists; 1997 May 17–20; Denver, Vol. 16, 449a...
Phase II study of cisplatin (CDDP), ifosfamide (IFX) and vinorelbine (VNR) in stage-IIIB-IV NSCLCdoi:10.1016/0169-5002(94)94203-XE. Baldini and C. Tibaldi and A. Ardizzoni and A. Chella and C.A. Angeletti and G. Silvano and P.F. Conte...